Skip to content
Search

Latest Stories

World Hypertension Day: Well Pharmacy offers free blood pressure checks in its branches

Well Pharmacy is offering free blood pressure checks in all its branches across England to raise awareness of the dangers posed by hypertension.

The leading independent pharmacy chain is inviting people to #thebigsqueeze in conjunction with May Measurement Month and World Hypertension Day (May 17) by inviting them to get a free blood pressure check and to learn more on the importance of understanding hypertension.


George Sandhu, deputy superintendent pharmacist at Well Pharmacy said: “May Measurement Month is a global blood pressure screening awareness campaign. The aim is to raise awareness of the dangers posed by elevated BP and hypertension. May 17 is World Hypertension Day, and a perfect time to take control and get your blood pressure checked.

“We are delighted to be supporting this campaign. Hypertension (more commonly known as high blood pressure) can cause a range of health issues.  Worryingly, it often comes with no symptoms, which is why it is vital to know if your blood pressure is higher people don’t have any symptoms of high blood pressure so having their blood pressure checked is the only way to find out.

"People can come into any of our Well Pharmacies across England and have their blood pressure checked. The theme for 2023 is Measure Your Blood Pressure Accurately, Control It, Live Longer – and knowing your number is one of the most important things people can do.

He continued: “We are urging people, particularly those with a family history, to come into our pharmacies across England in May as part of May Measure Month. Our pharmacy teams will be on hand to offer advice and information. Upon visiting, a pharmacist will measure the customers blood pressure in a private consultation room.

"If the reading is high, they may offer them an ambulatory blood pressure monitoring (ABPM) device to wear which could result in a referral to their GP. This automatically measures blood pressure at regular intervals over a 24-hour period, allowing for a more detailed view of what is happening.”

More For You

Pharmacist Support calls for birthday donations to meet rising demand for mental health services

More and more pharmacy professionals are reaching out for help, said Danielle Hunt.

Pharmacist Support's birthday appeal: Donate to address growing mental health demand

Pharmacist Support – the independent charity dedicated to the pharmacy profession – is celebrating 184 years of service with the launch of a special birthday donations appeal.

On 15 April, the charity is urging individuals and organisations across the sector to support its campaign to raise vital funds to meet the increasing demand for its mental health and wellbeing services.

Keep ReadingShow less
Prostate cancer: At-home saliva test could save NHS £500 million annually

PRS saliva test can identify prostate cancer that was missed by an MRI scan

Photo credit: gettyimages

Prostate cancer: Spit test better than blood test in spotting men at highest risk

A simple at-home spit test could help detect prostate cancer earlier, saving the NHS around £500 million a year, according to new research published in the New England Journal of Medicine.

Funded by the National Institute for Health and Care Research (NIHR), the study found that the DNA-based saliva test was more accurate than the current prostate-specific antigen (PSA) blood test in identifying men at risk of developing prostate cancer.

Keep ReadingShow less
RPS launches innovative new learning resources for members

With RPS Learn, pharmacists can develop a new skill or improve their understanding of practice or a clinical topic.

Gettyimages

RPS launches new learning resources to boost career development for members

The Royal Pharmaceutical Society (RPS) has launched a new online learning platform designed to support the practice, development and career advancement of its members.

The new platform, called RPS Learn, offers a diverse range of bite-size learning content, available on-demand, catering to all levels — from introductory to advanced and specialist —combining new content with RPS's renowned expertise in education and training to achieve excellence for learners.

Keep ReadingShow less
NICE approves AstraZeneca’s twice-a-day tablet ‘capivasertib’ for advanced breast cancer

HR-positive, HER2-negative advanced breast cancer is currently incurable, and treatment aims to slow progression and prolong life

Gettyimages

NICE approves twice-a-day tablet for advanced breast cancer

Every year, thousands of people with hormone receptor (HR)-positive HER2-negative breast cancer could benefit from a new twice-a-day tablet, now set to be funded immediately through the Cancer Drugs Fund.

The National Institute for Health and Care Excellence (NICE) has approved the use of capivasertib (also known as Truqap), in combination with fulvestrant, as an option for around 1,100 adults with HR-positive HER2-negative breast cancer that has certain genetic mutations and has spread.

Keep ReadingShow less
ABPI and government fast-track VPAG scheme review to address high medicine payment rates

The 2025 VPAG payment rate for newer medicines has been set at 22.9 per cent.

Photo credit: gettyimages

Review of 2024 VPAG scheme to be completed by June

The Association of the British Pharmaceutical Industry (ABPI) and the government have agreed to bring forward a planned review of the 2024 Voluntary Scheme for Branded Medicines Pricing, Access, and Growth (VPAG), originally scheduled for autumn 2025.

The review is expected to be completed in June 2025, aligning with the anticipated release of the government’s 10-year NHS Plan and the Life Sciences Sector Plan as part of the broader industry strategy this summer.

Keep ReadingShow less